You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Gastrointestinal ultrasound in inflammatory bowel disease: experience from the Chinese IBD Elite Union
  1. Ren Mao1,2,
  2. Yujun Chen3,
  3. Xiaoyan Xie3,
  4. Minhu Chen1
  1. 1 Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  2. 2 Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA
  3. 3 Department of Medical Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  1. Correspondence to Dr Ren Mao, Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China; maoren2023{at}gmail.com

https://doi.org/10.1136/gutjnl-2018-317070

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest a recent review by Bryant et al 1 presenting a pragmatic guide of GI ultrasound (GIUS) in IBD clinical practice. We agree with the authors that the uptake of GIUS outside Europe has been slow and GIUS is underused in many countries. Here we would like to introduce the status, challenge and opportunity of GIUS implementation in IBD clinical practice in a different region of the world, namely China. We have witnessed a striking increase in the incidence of IBD in China in the last decade.2 The concept of multidisciplinary team (MDT) care consisting of gastroenterologist, colorectal surgeon, radiologist, pathologist, dietitian, and so on has been integrated into daily clinical …

    View Full Text

    Footnotes

    • Contributors RM and MC are the guarantors of the article. RM drafted the manuscript. YC, XX and MC have approved the final draft submitted.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.